Nadia L. Mitchell

804 total citations
33 papers, 561 citations indexed

About

Nadia L. Mitchell is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Nadia L. Mitchell has authored 33 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 10 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Nadia L. Mitchell's work include Lysosomal Storage Disorders Research (22 papers), Virus-based gene therapy research (7 papers) and Neurological diseases and metabolism (5 papers). Nadia L. Mitchell is often cited by papers focused on Lysosomal Storage Disorders Research (22 papers), Virus-based gene therapy research (7 papers) and Neurological diseases and metabolism (5 papers). Nadia L. Mitchell collaborates with scholars based in New Zealand, United States and United Kingdom. Nadia L. Mitchell's co-authors include David N. Palmer, Stephanie M. Hughes, Imke Tammen, Peter J. Houweling, Tony Frugier, Graham W. Kay, Tracy R. Melzer, Julie Cavanagh, Herman W. Raadsma and Graham K. Barrell and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Nadia L. Mitchell

31 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia L. Mitchell New Zealand 15 353 187 181 82 81 33 561
Rebecca E.H. Whiting United States 12 296 0.8× 194 1.0× 135 0.7× 60 0.7× 36 0.4× 19 421
Stefanie Beck‐Wödl Germany 13 155 0.4× 178 1.0× 55 0.3× 76 0.9× 37 0.5× 27 401
Brian C. Richardson United States 15 140 0.4× 354 1.9× 338 1.9× 161 2.0× 29 0.4× 19 846
Marie-Louise Bondeson Sweden 15 76 0.2× 372 2.0× 60 0.3× 44 0.5× 40 0.5× 26 711
Marta Magariños Spain 13 63 0.2× 216 1.2× 56 0.3× 89 1.1× 44 0.5× 18 465
Sahana Nagabhushan Kalburgi United States 10 106 0.3× 417 2.2× 71 0.4× 61 0.7× 24 0.3× 16 740
Tsai-Yi Lu United States 7 64 0.2× 184 1.0× 48 0.3× 56 0.7× 195 2.4× 7 549
Charles‐Félix Calvo France 13 78 0.2× 291 1.6× 57 0.3× 36 0.4× 182 2.2× 20 780
Bianca Vaida Germany 11 44 0.1× 371 2.0× 119 0.7× 131 1.6× 23 0.3× 14 689
Chiara Di Pietro Italy 13 33 0.1× 333 1.8× 82 0.5× 144 1.8× 28 0.3× 33 634

Countries citing papers authored by Nadia L. Mitchell

Since Specialization
Citations

This map shows the geographic impact of Nadia L. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia L. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia L. Mitchell more than expected).

Fields of papers citing papers by Nadia L. Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia L. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia L. Mitchell. The network helps show where Nadia L. Mitchell may publish in the future.

Co-authorship network of co-authors of Nadia L. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia L. Mitchell. A scholar is included among the top collaborators of Nadia L. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia L. Mitchell. Nadia L. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Myall, Daniel J., et al.. (2025). Magnetic Resonance Imaging as a Readout of CLN5 Gene Therapy Efficacy in Sheep. Brain and Behavior. 15(4). e70431–e70431. 1 indexed citations
2.
Wellby, Martin, et al.. (2023). Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease. Frontiers in Pharmacology. 14. 1212235–1212235. 4 indexed citations
3.
Hunt, H.R., et al.. (2023). Retinopathy in Greyhound dogs: Prevalence, fundoscopic, and histopathological findings. Veterinary Ophthalmology. 27(4). 298–309.
4.
Mitchell, Nadia L., et al.. (2023). Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten disease. Frontiers in Genetics. 14. 1212228–1212228. 5 indexed citations
5.
Eaton, Samantha L., Nina M. Rzechorzek, Gerard Thompson, et al.. (2022). Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment. Cells. 11(17). 2641–2641. 4 indexed citations
6.
Mitchell, Nadia L., et al.. (2022). Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses. Scientific Reports. 12(1). 3670–3670. 4 indexed citations
7.
Mitchell, Nadia L., et al.. (2022). The Translational Benefits of Sheep as Large Animal Models of Human Neurological Disorders. Frontiers in Veterinary Science. 9. 831838–831838. 31 indexed citations
8.
Myall, Daniel J., et al.. (2022). Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis. Brain Communications. 5(1). fcac339–fcac339. 4 indexed citations
9.
Melzer, Tracy R., et al.. (2021). Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease. Experimental Eye Research. 207. 108600–108600. 19 indexed citations
10.
Mitchell, Nadia L., et al.. (2021). Ocular therapies for neuronal ceroid lipofuscinoses: more than meets the eye. Neural Regeneration Research. 17(8). 1755–1755. 3 indexed citations
11.
Mitchell, Nadia L., et al.. (2021). Electroretinography data from ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses. SHILAP Revista de lepidopterología. 37. 107188–107188. 7 indexed citations
12.
Mitchell, Nadia L., Martin Wellby, Lucia Schoderboeck, et al.. (2018). Longitudinal In Vivo Monitoring of the CNS Demonstrates the Efficacy of Gene Therapy in a Sheep Model of CLN5 Batten Disease. Molecular Therapy. 26(10). 2366–2378. 45 indexed citations
13.
Mitchell, Nadia L., et al.. (2017). Characterisation of early changes in ovine CLN5 and CLN6 Batten disease neural cultures for the rapid screening of therapeutics. Neurobiology of Disease. 100. 62–74. 27 indexed citations
14.
Palmer, David N., et al.. (2015). Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(10). 2279–2286. 26 indexed citations
15.
Sawiak, Stephen J., Sunthara Rajan Perumal, Skye R. Rudiger, et al.. (2015). Rapid and Progressive Regional Brain Atrophy in CLN6 Batten Disease Affected Sheep Measured with Longitudinal Magnetic Resonance Imaging. PLoS ONE. 10(7). e0132331–e0132331. 19 indexed citations
16.
Hughes, Stephanie M., et al.. (2013). Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy. Neurobiology of Disease. 62. 543–550. 31 indexed citations
17.
18.
Houweling, Peter J., Julie Cavanagh, David N. Palmer, et al.. (2006). Neuronal ceroid lipofuscinosis in Devon cattle is caused by a single base duplication (c.662dupG) in the bovine CLN5 gene. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(10). 890–897. 32 indexed citations
19.
Tammen, Imke, Peter J. Houweling, Tony Frugier, et al.. (2006). A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1762(10). 898–905. 61 indexed citations
20.
Mitchell, Nadia L., et al.. (2005). Rapid detection and characterisation of infectious bronchitis virus (IBV) from New Zealand using RT-PCR and sequence analysis. New Zealand Veterinary Journal. 53(6). 457–461. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca E.H. Whiting Breakdown of academic impact, for papers by Stefanie Beck‐Wödl Breakdown of academic impact, for papers by Brian C. Richardson Breakdown of academic impact, for papers by Marie-Louise Bondeson Breakdown of academic impact, for papers by Marta Magariños Breakdown of academic impact, for papers by Sahana Nagabhushan Kalburgi Breakdown of academic impact, for papers by Tsai-Yi Lu Breakdown of academic impact, for papers by Charles‐Félix Calvo Breakdown of academic impact, for papers by Bianca Vaida Breakdown of academic impact, for papers by Chiara Di Pietro
Rankless by CCL
2026